Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors

Details for Australian Patent Application No. 2002352126 (hide)

Owner F. HOFFMANN-LA ROCHE AG

Inventors Smith, David, Bernard; Krauss, Nancy, Elisabeth; Palmer, Wylie, Solang; Gabriel, Tobias; Mirzadegan, Taraneh

Agent Spruson & Ferguson

Pub. Number AU-A-2002352126

PCT Number PCT/EP02/13221

PCT Pub. Number WO2003/048123

Priority 60/336,750 04.12.01 US

Filing date 25 November 2002

Wipo publication date 17 June 2003

International Classifications

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/40 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/48 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/54 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/60 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 277/62 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 217/02 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 231/38 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/56 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 031/404

A61K 031/33 - Heterocyclic compounds

A61P 019/00 Drugs for skeletal disorders

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/336,750 04.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002352126

5 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352127-Method for producing perfluoroalkane sulfonic acid esters and the salts thereof

2002352125-4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists